IPACT

Image-guided pancreatic cancer therapy

 Coordinatore TECHNISCHE UNIVERSITEIT EINDHOVEN 

 Organization address address: DEN DOLECH 2
city: EINDHOVEN
postcode: 5612 AZ

contact info
Nome: Leon
Cognome: Luwijs
Email: send email
Telefono: 31402474313

 Nazionalità Coordinatore Netherlands [NL]
 Totale costo 8˙612˙064 €
 EC contributo 5˙991˙070 €
 Programma FP7-HEALTH
Specific Programme "Cooperation": Health
 Code Call FP7-HEALTH-2013-INNOVATION-1
 Funding Scheme CP-FP
 Anno di inizio 2014
 Periodo (anno-mese-giorno) 2014-01-01   -   2017-12-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    TECHNISCHE UNIVERSITEIT EINDHOVEN

 Organization address address: DEN DOLECH 2
city: EINDHOVEN
postcode: 5612 AZ

contact info
Nome: Leon
Cognome: Luwijs
Email: send email
Telefono: 31402474313

NL (EINDHOVEN) coordinator 1˙202˙326.00
2    IMASONIC SAS

 Organization address address: ZA RUE DES SAVOUROTS
city: VORAY SUR L'OGNON
postcode: 70190

contact info
Titolo: Mr.
Nome: Sebastien
Cognome: Ubbiali
Email: send email
Telefono: +33 381403131
Fax: +33 381403139

FR (VORAY SUR L'OGNON) participant 1˙259˙050.00
3    UNIVERSITAIR MEDISCH CENTRUM UTRECHT

 Organization address address: HEIDELBERGLAAN 100
city: UTRECHT
postcode: 3584 CX

contact info
Titolo: Ms.
Nome: Marieke
Cognome: Krispijn
Email: send email
Telefono: +31 88 75 57796

NL (UTRECHT) participant 1˙161˙600.00
4    PHILIPS ELECTRONICS NEDERLAND B.V.

 Organization address address: Boschdijk 525
city: EINDHOVEN
postcode: 5621JG

contact info
Titolo: Mr.
Nome: Patrick
Cognome: Keur
Email: send email
Telefono: +31 402740361

NL (EINDHOVEN) participant 1˙040˙459.00
5    NEAGEN OY

 Organization address address: KIRKKOKATU 12
city: OULU
postcode: 90630

contact info
Titolo: Mr.
Nome: Lasse
Cognome: Jyrkinen
Email: send email
Telefono: 358405000000

FI (OULU) participant 538˙500.00
6    LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN

 Organization address address: GESCHWISTER SCHOLL PLATZ 1
city: MUENCHEN
postcode: 80539

contact info
Titolo: Dr.
Nome: Lars
Cognome: Lindner
Email: send email
Telefono: 498971000000

DE (MUENCHEN) participant 497˙400.00
7    Philips GmbH

 Organization address address: Luebeckertordamm 5
city: Hamburg
postcode: 20099

contact info
Titolo: Mr.
Nome: Frans
Cognome: Pelgrim
Email: send email
Telefono: +31 402740363

DE (Hamburg) participant 195˙485.00
8    PHILIPS OY

 Organization address address: AYRITIE 4
city: VANTAA
postcode: 1511

contact info
Titolo: Ms.
Nome: Johanna
Cognome: Tanhuamaki
Email: send email
Telefono: +358 961580400

FI (VANTAA) participant 96˙250.00
9    PHILIPS TECHNOLOGIE GMBH

 Organization address address: LUEBECKERTORDAM 5
city: HAMBURG
postcode: 20099

contact info
Titolo: Mr.
Nome: Frans
Cognome: Pelgrim
Email: send email
Telefono: +31 402740363

DE (HAMBURG) participant 0.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

temperature    diagnosed    image    local    mr    company    drug    cancer    route    us       smes    platform    hifu    guided    pancreatic    therapy    thermal    medical    university    ultrasound    imaging    clinical   

 Obiettivo del progetto (Objective)

'The aim of the iPaCT project is to address the unmet clinical need for an improved therapy of pancreatic cancer by developing a new integrated technology platform for image-guided thermal therapy. Yearly, 280000 new cases of pancreatic cancer are diagnosed worldwide. Being usually diagnosed late stage and without any efficient therapy available, basically all patients die with an average life expectancy of only a few months after diagnosis, leading to an overall low prevalence in society. Therefore, pancreatic cancer is a rare disease with an urgent clinical need for a new and improved therapeutic option.

A potential breakthrough solution for the treatment of pancreatic cancer can be found in thermal therapies using high intensity focused ultrasound (HIFU) combined with local, temperature-triggered drug delivery. We propose a novel US-MR-HIFU system that integrates HIFU with two imaging modalities, i.e. Magnetic Resonance Imaging (MRI) and diagnostic Ultrasound (US) for image guidance of thermal ablation (T=60⁰C) and/or hyperthermia (T=42-43⁰C) of pancreatic tumours. For image-guided drug delivery, new temperature-sensitive nanocarriers will be developed that provide a high local dose of chemotherapeutic drug. Multimodal (molecular) imaging information, simultaneously acquired using the US-MR-HIFU platform, provides motion compensated temperature feedback as well as visualization of perfusion and drug uptake in the target tissue allowing personalized therapy. The consortium, including two innovative SMEs (Imasonic, Neagen), two hospitals (Klinikum der Universität München and University Medical Center Utrecht), Eindhoven University of Technology and Philips (a medical device company), represents the total chain from technology development, preclinical testing to clinical translation guaranteeing a clear route for later clinical use and a route to market for the SMEs partners, leveraging the competencies and strengths of a leading global healthcare company.'

Altri progetti dello stesso programma (FP7-HEALTH)

FEMHEALTH (2011)

"Assessing the impact of fee exemption on maternal health in West Africa and Morocco: new tools, new knowledge"

Read More  

PORTFASTFLU (2008)

Portable automated test for fast detection and surveillance of influenza

Read More  

KINDRED (2013)

Kinetoplastid Drug Development: strengthening the preclinical pipeline

Read More